Margaret A. Echerd
Net Worth

Last updated:

What is Margaret A. Echerd net worth?

The estimated net worth of Ms. Margaret A. Echerd is at least $2,548,741 as of 30 Nov 2021. She owns shares worth $119 as insider, has earned $456,342 from insider trading and has received compensation worth at least $2,092,280 in Vaxart, Inc..

What is the salary of Margaret A. Echerd?

Ms. Margaret A. Echerd salary is $523,070 per year as Senior Vice President & Principal Accounting Officer in Vaxart, Inc..

How old is Margaret A. Echerd?

Ms. Margaret A. Echerd is 66 years old, born in 1959.

What stocks does Margaret A. Echerd currently own?

As insider, Ms. Margaret A. Echerd owns shares in one company:

Company Title Shares Price per share Total value
Vaxart, Inc. (VXRT) Senior Vice President & Principal Accounting Officer 334 $0.36 $119

What does Vaxart, Inc. do?

Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trial for the treatment of H1 influenza infection; respiratory syncytial virus vaccine; and coronavirus vaccine, which is in Phase II clinical trial for the treatment of SARS-CoV-2 infection. It is also developing therapeutic vaccines for cervical cancer and dysplasia caused by human papillomavirus. The company is headquartered in South San Francisco, California.

VXRT logo
VXRT
Vaxart, Inc.
$0.36

Margaret A. Echerd insider trading

Vaxart, Inc.

Ms. Margaret A. Echerd has made 7 insider trades in 2021, according to the Form 4 filled with the SEC.

The largest trade she's ever made was exercising 47,555 units of VXRT stock on 9 Jun 2021. As of 30 Nov 2021 she still owns at least 334 units of VXRT stock.

Transaction Date Security Shares Price per share Total value Source
Option
Stock Option (right to buy) 666 $5.17 $3,443
Option
Common Stock 2,936 $0.77 $2,261
Option
Stock Option (right to buy) 2,936 $0.77 $2,261
Sale
Common Stock 3,602 $8 $28,816
Option
Common Stock 666 $5.17 $3,443
Sale
Common Stock 1,801 $2.97 $5,349
Option
Stock Option (Right to Buy) 334 $5.17 $1,727
Option
Common Stock 1,467 $0.77 $1,130
Option
Stock Option (Right to Buy) 1,801 $5.17 $9,311
Sale
Stock Option (Right to Buy) 1,801 $5.17 $9,311
Option
Common Stock 1,801 $9.1 $16,389
Sale
Common Stock 1,801 $10 $18,010
Option
Common Stock 1,801 $2.97 $5,349
Option
Stock Option (right to buy) 1,801 $2.97 $5,349
Sale
Common Stock 1,800 N/A N/A
Option
Stock Option (right to buy) 1,800 $2.97 $5,346
Option
Stock Option (right to buy) 1,800 N/A N/A
Option
Common Stock 1,800 N/A N/A
Option
Common Stock 1,800 $2.97 $5,346
Option
Stock Option (right to buy) 1,802 $2.97 $5,352
Option
Common Stock 1,802 $2.97 $5,352
Option
Stock Option (right to buy) 1,802 $2.97 $5,352
Sale
Common Stock 1,802 $8 $14,416
Option
Common Stock 1,802 $2.97 $5,352
Option
Common Stock 47,555 $2.97 $141,238
Option
Stock Option (right to buy) 47,555 $2.97 $141,238
Sale
Common Stock 47,555 $8 $380,440

Vaxart key executives

Vaxart, Inc. executives and other stock owners filed with the SEC:

  • Dr. Sean N. Tucker (57) Senior Vice President & Chief Scientific Officer
  • Mr. Cezar Andrei Floroiu M.B.A. (52) Chief Executive Officer, Pres, Principal Financial Officer & Director
  • Ms. Margaret A. Echerd (66) Senior Vice President & Principal Accounting Officer